New common name provisionally approved on 9th January 2026 for an RNAI virucide from S company Development code SG-001.

RNA (recombinant tobacco mosaic virus coat protein mRNA-specific double-stranded interfering) [3052205-09-8]

Please contact the Maintenance Agency no later then 9th July 2026 for any objections (for example, the name ″tomovircona″ infringes on any trademarks). If no objections are received, then the name ″tomovircona″ will become approved and will be included in a new edition of ISO 1750 that will include preferred names as well as common names.